Updates in lung cancer screening
Prof Annemiek Snoeckx from the University Hospital in Antwerp presented the latest updates on screening at WCLC. One of the main topics that received a lot of attention was recruiting participants in screening trials. Unlike European studies, the meeting mainly focused on Asian trials that aimed at screening nonsmokers. Moreover, there is a shift in recruitment protocols towards using prediction models. Nowadays, the value of screening is widely recognised, and most countries have started population-based screening. Artificial intelligence in the context of screening is a hot topic and can be utilised at various levels, as explained by Professor Snoeckx. Another critical but challenging issue discussed was overdiagnosis, which is a consequence of more CT scans and screening protocols. Moving from trials to population-based screening requires quality assurance that should ideally be organised at a global level, according to Professor Snoeckx. The role of biomarkers and their potential use in screening is unclear, but it was undoubtedly another popular topic at this year’s WCLC.
With the educational support of:
